Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALKS · against 194 other Healthcare companies of similar size
Ranked #129 of 195 · scores higher than 31% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 40–49, including ALKS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ALKS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 193 reported | 0.8% | 2.4% | 34% | 30% | |
| EBITDA yieldHigher is better · 194 reported | 3.3% | 4.5% | 40% | 50% | |
| Free cash flow yieldHigher is better · 116 reported | 2.9% | 1.2% | 64% | 20% | |
| Book yieldHigher is better · 194 reported | 23.6% | 20.5% | 53% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 125 | 4.6B USD | 43 | 65 | |
| 127 | 5.1B USD | 42 | 52 | |
| 127 | 5.8B USD | 42 | 38 | |
| 129 | 64.1B CNY (≈$9.0B) | 41 | 48 | |
| 129 | 7.7B USD | 41 | 37 | |
| 129 | 593.2B INR (≈$7.1B) | 41 | 47 | |
| 129 | 13.2B USD | 41 | 30 | |
| 129 | 10.8B USD | 41 | 41 | |
| 129 | 12.6B USD | 41 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score